ArticleBreast cancer research : BCR2013

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.

Shuiliang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.